Table
1:
Patient
characteristics.
Variable |
Steroid (+) |
Steroid (-) |
p-value |
Age |
52.0 ± 15.3 |
52.0 ± 13.0 |
0.617 |
Sex (male/female) |
29/36 |
38/38 |
0.612 |
GRWR |
0.89 ± 0.59 |
0.92 ± 0.40 |
0.630 |
MELD score |
17.0± 8.71 |
19.0 ± 8.94 |
0.838 |
Child-Pugh class A:B/C |
19/46 |
23/53 |
1.000 |
Graft |
0.349 |
||
Lt |
32 |
35 |
|
Rt |
23 |
39 |
|
Whole |
8 |
2 |
|
Post |
2 |
0 |
|
Underlying disease |
|
|
0.561 |
Hepatocellular carcinoma |
15 |
10 |
|
Viral hepatitis B/C-related cirrhosis |
16 |
21 |
|
PBC/PSC |
11 |
18 |
|
Acute liver failure |
7 |
4 |
|
Biliary atresia after Kasai operation |
4 |
10 |
|
Alcoholic cirrhosis |
3 |
4 |
|
Others |
9 |
9 |
|
GRWR: Graft-to-Recipient
Weight Ratio, MELD score: Model for End-stage Liver Disease score, Lt: Left lobe
graft, Rt: Right lobe graft,
Whole: Whole
liver graft, Post: Posterior segment graft, PBC: Primary biliary cirrhosis,
PSC: Primary Sclerosing Cholangitis,
Steroid (+): Steroid-containing
protocol, Steroid (-): Steroid-free protocol